109TiPAcSé immunotherapy trials: Anti-PD-1 therapy for adult patients with selected rare cancer types. (17th December 2018) - Marabelle, A; Chevret, S; Janot, F; Escudier, B; Pouessel, D; Tournigand, C; Hoang-Xuan, K; Mortier, L; Rousseau, B J-C; Schlumberger, M J; Ray-Coquard, I L; Blay, J-Y; et al.